3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Lung Neoplasms
11
Head and Neck Neoplasms
5
Breast Neoplasms
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Gliosarcoma
2
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma
2
Brain Neoplasms
2
Adenocarcinoma Of Esophagus
2
Urinary Bladder Neoplasms
1
Untreated Childhood Anaplastic Astrocytoma
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Salivary Gland Neoplasms
1
Recurrence
1
Pleural Effusion, Malignant
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Squamous Cell
1
Lymphoid Interstitial Pneumonia
1
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
1
Interventions
Pemetrexed
3
Carboplatin
3
selpercatinib
2
pralsetinib
2
pembrolizumab
2
sotorasib
1
sitravatinib
1
patritumab
1
osimertinib
1
demcizumab
1
cobimetinib
1
atezolizumab
1
aflibercept
1
Tyrosine Kinase Inhibitors
1
Paclitaxel
1
Nivolumab
1
Ipilimumab
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Bevacizumab
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lung Diseases
×
Gefitinib
×
Clear all
No trials found.